Teva is laying off some 2,900 of its employees worldwide by 2027, corresponding to an approximately 8% reduction in force, company executives announced Wednesday during the company’s first-quarter 2025 earnings report, according to various media reports. According to a subsequent Worker Adjustment and Retraining Notification notice and confirmed by a company spokesperson to BioSpace via email, 54 of the affected employees work in Salt Lake City.
All entries for: Teva Pharmaceuticals
May 8, 2025
Teva Pharmaceuticals
Layoffs
Tel Aviv, Israel
10,001-50,000 employees
Disease Area: Immune Diseases, Multiple, Neurological Diseases, Oncology, Respiratory Diseases
Drug Type: Biologic, Small Molecule